Cargando…

Identification of a haem domain in human soluble adenylate cyclase

The second messengers cAMP and cGMP mediate a multitude of physiological processes. In mammals, these cyclic nucleotides are formed by related Class III nucleotidyl cyclases, and both ACs (adenylate cyclases) and GCs (guanylate cyclases) comprise transmembrane receptors as well as soluble isoforms....

Descripción completa

Detalles Bibliográficos
Autores principales: Middelhaufe, Sabine, Leipelt, Martina, Levin, Lonny R., Buck, Jochen, Steegborn, Clemens
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475452/
https://www.ncbi.nlm.nih.gov/pubmed/22775536
http://dx.doi.org/10.1042/BSR20120051
_version_ 1782246945340784640
author Middelhaufe, Sabine
Leipelt, Martina
Levin, Lonny R.
Buck, Jochen
Steegborn, Clemens
author_facet Middelhaufe, Sabine
Leipelt, Martina
Levin, Lonny R.
Buck, Jochen
Steegborn, Clemens
author_sort Middelhaufe, Sabine
collection PubMed
description The second messengers cAMP and cGMP mediate a multitude of physiological processes. In mammals, these cyclic nucleotides are formed by related Class III nucleotidyl cyclases, and both ACs (adenylate cyclases) and GCs (guanylate cyclases) comprise transmembrane receptors as well as soluble isoforms. Whereas sGC (soluble GC) has a well-characterized regulatory HD (haem domain) that acts as a receptor for the activator NO (nitric oxide), very little is known about the regulatory domains of the ubiquitous signalling enzyme sAC (soluble AC). In the present study, we identify a unique type of HD as a regulatory domain in sAC. The sAC-HD (sAC haem domain) forms a larger oligomer and binds, non-covalently, one haem cofactor per monomer. Spectral analyses and mutagenesis reveal a 6-fold co-ordinated haem iron atom, probably with non-typical axial ligands, which can bind both NO and CO (carbon monoxide). Splice variants of sAC comprising this domain are expressed in testis and skeletal muscle, and the HD displays an activating effect on the sAC catalytic core. Our results reveal a novel mechanism for regulation of cAMP signalling and suggest a need for reanalysis of previous studies on mechanisms of haem ligand effects on cyclic nucleotide signalling, particularly in testis and skeletal muscle.
format Online
Article
Text
id pubmed-3475452
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-34754522012-10-31 Identification of a haem domain in human soluble adenylate cyclase Middelhaufe, Sabine Leipelt, Martina Levin, Lonny R. Buck, Jochen Steegborn, Clemens Biosci Rep Original Paper The second messengers cAMP and cGMP mediate a multitude of physiological processes. In mammals, these cyclic nucleotides are formed by related Class III nucleotidyl cyclases, and both ACs (adenylate cyclases) and GCs (guanylate cyclases) comprise transmembrane receptors as well as soluble isoforms. Whereas sGC (soluble GC) has a well-characterized regulatory HD (haem domain) that acts as a receptor for the activator NO (nitric oxide), very little is known about the regulatory domains of the ubiquitous signalling enzyme sAC (soluble AC). In the present study, we identify a unique type of HD as a regulatory domain in sAC. The sAC-HD (sAC haem domain) forms a larger oligomer and binds, non-covalently, one haem cofactor per monomer. Spectral analyses and mutagenesis reveal a 6-fold co-ordinated haem iron atom, probably with non-typical axial ligands, which can bind both NO and CO (carbon monoxide). Splice variants of sAC comprising this domain are expressed in testis and skeletal muscle, and the HD displays an activating effect on the sAC catalytic core. Our results reveal a novel mechanism for regulation of cAMP signalling and suggest a need for reanalysis of previous studies on mechanisms of haem ligand effects on cyclic nucleotide signalling, particularly in testis and skeletal muscle. Portland Press Ltd. 2012-08-08 2012-10-01 /pmc/articles/PMC3475452/ /pubmed/22775536 http://dx.doi.org/10.1042/BSR20120051 Text en © 2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited
spellingShingle Original Paper
Middelhaufe, Sabine
Leipelt, Martina
Levin, Lonny R.
Buck, Jochen
Steegborn, Clemens
Identification of a haem domain in human soluble adenylate cyclase
title Identification of a haem domain in human soluble adenylate cyclase
title_full Identification of a haem domain in human soluble adenylate cyclase
title_fullStr Identification of a haem domain in human soluble adenylate cyclase
title_full_unstemmed Identification of a haem domain in human soluble adenylate cyclase
title_short Identification of a haem domain in human soluble adenylate cyclase
title_sort identification of a haem domain in human soluble adenylate cyclase
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475452/
https://www.ncbi.nlm.nih.gov/pubmed/22775536
http://dx.doi.org/10.1042/BSR20120051
work_keys_str_mv AT middelhaufesabine identificationofahaemdomaininhumansolubleadenylatecyclase
AT leipeltmartina identificationofahaemdomaininhumansolubleadenylatecyclase
AT levinlonnyr identificationofahaemdomaininhumansolubleadenylatecyclase
AT buckjochen identificationofahaemdomaininhumansolubleadenylatecyclase
AT steegbornclemens identificationofahaemdomaininhumansolubleadenylatecyclase